Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 9-methyl-3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidin-4-one
2. 9-tbx
3. Alamast
4. Bmy 26517
5. Bmy-26517
6. Pemirolast
7. Pemirolast Potassium Salt
1. 100299-08-9
2. Alamast
3. Pemirolast Potassium Salt
4. Pemilaston
5. Alegysal
6. Bmy 26517
7. Bmy-26517
8. Twt-8152
9. 497a17ouue
10. Tbx
11. 100299-08-9 (potassium)
12. 9-methyl-3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidin-4-one, Potassium Salt
13. Potassium 5-(9-methyl-4-oxo-4h-pyrido[1,2-a]pyrimidin-3-yl)tetrazol-1-ide
14. 4h-pyrido(1,2-a)pyrimidin-4-one, 9-methyl-3-(1h-tetrazol-5-yl)-, Potassium Salt
15. Dsstox_cid_26623
16. Dsstox_rid_81773
17. Dsstox_gsid_46623
18. 9-methyl-3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidin-4-one Potassium Salt
19. 9-methyl-3-(1h-tetrazol-5-yl)-4h-pyrido[1,2-a]pyrimidin-4-one Potassium Salt
20. Ccris 3562
21. Cas-100299-08-9
22. Pemirolast Potassium [usan:jan]
23. Ncgc00167434-01
24. Unii-497a17ouue
25. Pemilaston (tn)
26. Alegysal (tn)
27. Alamast (tn)
28. Permirolast Potassium
29. Pemirolast Potassium- Bio-x
30. Alamast, Pemirolast Potassium
31. Schembl865789
32. Chembl1201050
33. Dtxsid7046623
34. Hms3713g17
35. Pemirolast Potassium [jan]
36. Pemirolast Potassium [usan]
37. Bcp21138
38. Pemirolast Potassium (jp17/usan)
39. Pemirolast Potassium [vandf]
40. Tox21_112438
41. Bdbm50248065
42. De-068
43. Pemirolast (bmy 26517) Potassium
44. Pemirolast Potassium [mart.]
45. Permirolast Potassium [vandf]
46. S4008
47. Pemirolast Potassium [who-dd]
48. Akos015901748
49. Pemirolast Potassium Salt [mi]
50. Tox21_112438_1
51. Ac-8303
52. Ccg-220358
53. Hs-0020
54. Pemirolast Potassium, >=98% (hplc)
55. Sb18793
56. Ncgc00167434-02
57. Ac-22387
58. Bp164244
59. Pemirolast Potassium [orange Book]
60. Ft-0631005
61. P1995
62. P2547
63. D01088
64. T71519
65. 299p089
66. J-000087
67. Q27259246
68. 9-methyl-3-(2h-tetrazol-5-yl)-4h-pyrido[1,2-a]pyrimidin-4-one Potassium Salt;alamast
69. Potassium;9-methyl-3-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)pyrido[1,2-a]pyrimidin-4-one
| Molecular Weight | 266.30 g/mol |
|---|---|
| Molecular Formula | C10H7KN6O |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 1 |
| Exact Mass | 266.03184035 g/mol |
| Monoisotopic Mass | 266.03184035 g/mol |
| Topological Polar Surface Area | 72.3 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 495 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Histamine Antagonists
Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Pemirolast manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pemirolast, including repackagers and relabelers. The FDA regulates Pemirolast manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pemirolast API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Pemirolast supplier is an individual or a company that provides Pemirolast active pharmaceutical ingredient (API) or Pemirolast finished formulations upon request. The Pemirolast suppliers may include Pemirolast API manufacturers, exporters, distributors and traders.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Pemirolast Drug Master File in Korea (Pemirolast KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Pemirolast. The MFDS reviews the Pemirolast KDMF as part of the drug registration process and uses the information provided in the Pemirolast KDMF to evaluate the safety and efficacy of the drug.
After submitting a Pemirolast KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Pemirolast API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Pemirolast suppliers with KDMF on PharmaCompass.
Pemirolast Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pemirolast GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pemirolast GMP manufacturer or Pemirolast GMP API supplier for your needs.
A Pemirolast CoA (Certificate of Analysis) is a formal document that attests to Pemirolast's compliance with Pemirolast specifications and serves as a tool for batch-level quality control.
Pemirolast CoA mostly includes findings from lab analyses of a specific batch. For each Pemirolast CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pemirolast may be tested according to a variety of international standards, such as European Pharmacopoeia (Pemirolast EP), Pemirolast JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pemirolast USP).
LOOKING FOR A SUPPLIER?
